Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/116147

Documents

Beta release

Statistics of A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis
Statistics for this year
PeriodVisitsDownloads
20241515
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0800
2024-0955
2024-1000